nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—leg—multiple sclerosis	0.0333	0.676	CbGeAlD
Ximelagatran—F2—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.0322	0.0339	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.0322	0.0339	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.0322	0.0339	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—CCL5—multiple sclerosis	0.0192	0.0202	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—ICAM1—multiple sclerosis	0.0186	0.0196	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0186	0.0196	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0186	0.0196	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—CCL2—multiple sclerosis	0.0167	0.0175	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IFNG—multiple sclerosis	0.0142	0.0149	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.014	0.0147	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.0132	0.0139	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL1B—multiple sclerosis	0.0127	0.0133	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—multiple sclerosis	0.0119	0.0125	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0118	0.0124	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0118	0.0124	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.0117	0.0123	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.0117	0.0123	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—GPR65—multiple sclerosis	0.0111	0.0117	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.0109	0.0114	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.0105	0.011	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL4—multiple sclerosis	0.0104	0.011	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.0102	0.0107	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.0101	0.0107	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.01	0.0106	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.01	0.0106	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00994	0.0105	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00959	0.0101	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00959	0.0101	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.00957	0.0101	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—multiple sclerosis	0.00948	0.00997	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00913	0.00961	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.00913	0.0096	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CD58—multiple sclerosis	0.00873	0.00918	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MERTK—multiple sclerosis	0.00873	0.00918	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SELPLG—multiple sclerosis	0.00873	0.00918	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.00851	0.00895	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ICAM1—multiple sclerosis	0.0083	0.00873	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.00776	0.00816	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—multiple sclerosis	0.00766	0.00806	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—CCL2—multiple sclerosis	0.00743	0.00781	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00736	0.00774	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00715	0.00752	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—S1PR1—multiple sclerosis	0.00695	0.00731	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.00692	0.00728	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—multiple sclerosis	0.00692	0.00728	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00673	0.00708	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00673	0.00708	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00665	0.00699	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.00659	0.00693	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00647	0.0068	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IFNG—multiple sclerosis	0.00631	0.00664	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.0061	0.00641	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.0059	0.00621	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—multiple sclerosis	0.00563	0.00592	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—multiple sclerosis	0.00561	0.0059	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GPR65—multiple sclerosis	0.00561	0.0059	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.0055	0.00578	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLEK—multiple sclerosis	0.00539	0.00567	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00537	0.00565	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.00536	0.00564	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL13—multiple sclerosis	0.00513	0.00539	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR1—multiple sclerosis	0.00513	0.00539	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.0051	0.00537	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00509	0.00536	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00509	0.00536	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.00502	0.00528	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00502	0.00528	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00502	0.00528	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.00502	0.00528	CbGpPWpGaD
Ximelagatran—F2—spinal cord—multiple sclerosis	0.00483	0.098	CbGeAlD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.0048	0.00505	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00463	0.00487	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00462	0.00486	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.00447	0.00471	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00446	0.00469	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00434	0.00456	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—SLC30A7—multiple sclerosis	0.00424	0.00446	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00417	0.00438	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—multiple sclerosis	0.00409	0.0043	CbGpPWpGaD
Ximelagatran—F2—nervous system—multiple sclerosis	0.00407	0.0826	CbGeAlD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.00405	0.00426	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.004	0.00421	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00393	0.00413	CbGpPWpGaD
Ximelagatran—F2—central nervous system—multiple sclerosis	0.00392	0.0795	CbGeAlD
Ximelagatran—F2—Hemostasis—SELE—multiple sclerosis	0.0038	0.004	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL3—multiple sclerosis	0.00365	0.00384	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00364	0.00383	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00361	0.00379	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00357	0.00375	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00352	0.0037	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PABPC1—multiple sclerosis	0.00343	0.00361	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCR3—multiple sclerosis	0.0034	0.00357	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00334	0.00351	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR2—multiple sclerosis	0.0033	0.00347	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—multiple sclerosis	0.0033	0.00347	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00326	0.00343	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00325	0.00341	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00319	0.00335	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00317	0.00333	CbGpPWpGaD
Ximelagatran—F2—brain—multiple sclerosis	0.00311	0.0631	CbGeAlD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0031	0.00326	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—RPL5—multiple sclerosis	0.00309	0.00325	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CNR1—multiple sclerosis	0.00305	0.00321	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RGS1—multiple sclerosis	0.00303	0.00319	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.0029	0.00305	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR1—multiple sclerosis	0.0029	0.00305	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GPR65—multiple sclerosis	0.00288	0.00303	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.0028	0.00294	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LINGO1—multiple sclerosis	0.00278	0.00293	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ITGA4—multiple sclerosis	0.00275	0.00289	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00275	0.00289	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNB1—multiple sclerosis	0.00273	0.00287	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00266	0.0028	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00263	0.00277	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR1—multiple sclerosis	0.00263	0.00277	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00263	0.00277	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00262	0.00276	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.00262	0.00276	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TAGAP—multiple sclerosis	0.00241	0.00254	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL5—multiple sclerosis	0.00236	0.00249	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—BCHE—multiple sclerosis	0.00226	0.00238	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.00224	0.00235	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00219	0.0023	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00216	0.00227	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00214	0.00225	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00213	0.00224	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR5—multiple sclerosis	0.00213	0.00224	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S1PR1—multiple sclerosis	0.00211	0.00222	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GPC5—multiple sclerosis	0.00205	0.00216	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00199	0.00209	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00196	0.00206	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00196	0.00206	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00192	0.00202	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2RA—multiple sclerosis	0.00188	0.00197	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL3—multiple sclerosis	0.00187	0.00197	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00187	0.00196	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTGER4—multiple sclerosis	0.0018	0.0019	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RGS1—multiple sclerosis	0.00179	0.00189	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00174	0.00183	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00172	0.00181	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GPR65—multiple sclerosis	0.0017	0.00179	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR2—multiple sclerosis	0.0017	0.00178	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00167	0.00176	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00166	0.00175	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—multiple sclerosis	0.00166	0.00175	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.00163	0.00172	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—multiple sclerosis	0.00163	0.00171	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR1—multiple sclerosis	0.00156	0.00165	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR1—multiple sclerosis	0.00155	0.00163	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL13—multiple sclerosis	0.00155	0.00163	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00155	0.00163	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00141	0.00148	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—multiple sclerosis	0.00136	0.00143	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00134	0.0014	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00128	0.00135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SRM—multiple sclerosis	0.00124	0.0013	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL5—multiple sclerosis	0.00121	0.00128	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—multiple sclerosis	0.0012	0.00127	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00119	0.00125	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—multiple sclerosis	0.00117	0.00123	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.00115	0.0012	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—multiple sclerosis	0.00115	0.0012	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL3—multiple sclerosis	0.00111	0.00116	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—multiple sclerosis	0.0011	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—multiple sclerosis	0.00109	0.00115	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00108	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTGER4—multiple sclerosis	0.00107	0.00112	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PGR—multiple sclerosis	0.00105	0.0011	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCR3—multiple sclerosis	0.00103	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CD28—multiple sclerosis	0.00102	0.00107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR2—multiple sclerosis	0.001	0.00105	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—multiple sclerosis	0.00094	0.000989	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR1—multiple sclerosis	0.000924	0.000972	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.000871	0.000916	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.000871	0.000916	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—multiple sclerosis	0.000858	0.000902	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—multiple sclerosis	0.000854	0.000898	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000851	0.000895	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK1—multiple sclerosis	0.000841	0.000885	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—multiple sclerosis	0.000835	0.000879	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL10—multiple sclerosis	0.000832	0.000875	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPC5—multiple sclerosis	0.000797	0.000838	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TYK2—multiple sclerosis	0.000759	0.000798	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CD86—multiple sclerosis	0.000728	0.000765	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL5—multiple sclerosis	0.000716	0.000753	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—multiple sclerosis	0.000695	0.000731	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPP1—multiple sclerosis	0.000663	0.000698	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RRM1—multiple sclerosis	0.00066	0.000694	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—multiple sclerosis	0.000645	0.000679	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2RA—multiple sclerosis	0.000636	0.000669	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—multiple sclerosis	0.000631	0.000664	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—multiple sclerosis	0.000587	0.000618	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CD80—multiple sclerosis	0.000531	0.000558	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000512	0.000539	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—multiple sclerosis	0.000504	0.000531	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—multiple sclerosis	0.000494	0.000519	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000483	0.000508	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TYK2—multiple sclerosis	0.000448	0.000471	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00044	0.000463	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000401	0.000422	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—multiple sclerosis	0.000379	0.000399	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—multiple sclerosis	0.000373	0.000392	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—multiple sclerosis	0.000371	0.00039	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—multiple sclerosis	0.000353	0.000371	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—multiple sclerosis	0.000314	0.00033	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—multiple sclerosis	0.000292	0.000307	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—multiple sclerosis	0.000291	0.000306	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK1—multiple sclerosis	0.000285	0.0003	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—multiple sclerosis	0.000228	0.00024	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—multiple sclerosis	0.000219	0.000231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—multiple sclerosis	0.000196	0.000206	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—multiple sclerosis	0.000179	0.000188	CbGpPWpGaD
